Inventor · disambiguated record
Aleksey I. Gerasyuto
Also filed as: GERASYUTO ALEKSEY · GERASYUTO ALEKSEY I
23 granted patents·11 pending applications·70 citations·filing 2012–2024
94Inventor score
Files withMORPHIC THERAPEUTIC INC19HIBERCELL INC4PTC THERAPEUTICS INC3BRANSTROM ARTHUR2PETRA PHARMA CORP2
Top patents by PatentIndex Score
34 records- 0196US12145935B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2023·Granted Nov 19, 2024·4 cites·20 claims
- 0296US11795167B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Oct 24, 2023·5 cites·19 claims
- 0395US11827621B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Nov 28, 2023·5 cites·9 claims
- 0495US11021480B2Inhibiting (α-V)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Granted Jun 1, 2021·8 cites·2 claims
- 0594US12415796B2Inhibitors of (αv)(β6) integrinMORPHIC THERAPEUTIC INC·Filed 2023·Granted Sep 16, 2025·2 cites·8 claims
- 0694US11739087B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2021·Granted Aug 29, 2023·5 cites·9 claims
- 0794US11046669B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Granted Jun 29, 2021·8 cites·35 claims
- 0893US11046685B2Inhibitors of (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2018·Granted Jun 29, 2021·8 cites·42 claims
- 0993US11040955B2Inhibitors of (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2018·Granted Jun 22, 2021·8 cites·59 claims
- 1093US10759756B2Antagonists of human integrin α4β7MORPHIC THERAPEUTIC INC·Filed 2019·Granted Sep 1, 2020·7 cites·42 claims
- 1189US11370773B1Inhibiting human integrin (alpha-4) (beta-7)MORPHIC THERAPEUTIC INC·Filed 2021·Granted Jun 28, 2022·2 cites·24 claims
- 1285US12459942B2Inhibiting (α-v)(β-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Granted Nov 4, 2025·0 cites·18 claims
- 1385US12221416B2Antagonists of human integrin α4β7MORPHIC THERAPEUTIC INC·Filed 2023·Granted Feb 11, 2025·0 cites·20 claims
- 1484US2025223289A1Inhibitors of (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2024·Application pending·0 cites
- 1583US11174228B2Antagonists of human integrin (α4)(β7)MORPHIC THERAPEUTIC INC·Filed 2020·Granted Nov 16, 2021·1 cites·20 claims
- 1681US11649227B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2021·Granted May 16, 2023·1 cites·20 claims
- 1781US11104661B1Inhibiting human integrin (α-4) (β-7)MORPHIC THERAPEUTIC INC·Filed 2020·Granted Aug 31, 2021·1 cites·24 claims
- 1878US11667651B2Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Jun 6, 2023·1 cites·11 claims
- 1976US9409905B2Antibacterial compounds and methods for useBRANSTROM ARTHUR·Filed 2012·Granted Aug 9, 2016·4 cites·21 claims
- 2072US2022340529A1Antagonists of human integrin (alpha4)(beta7)MORPHIC THERAPEUTIC INC·Filed 2021·Application pending·0 cites
- 2170US2024158415A1Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 2268US2020071322A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2019·Application pending·0 cites
- 2367US2020354359A1Inhibiting (alpha-v)(beta-6) integrinMORPHIC THERAPEUTIC INC·Filed 2020·Application pending·0 cites
- 2466US2023286960A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 2562US2024132509A1Heterocyclic and heteroaryl compounds for treating huntington's diseasePTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2659US11858941B2Heterocyclic and heteroaryl compounds for treating Huntington's diseasePTC THERAPEUTICS INC·Filed 2019·Granted Jan 2, 2024·0 cites·16 claims
- 2751US2023219949A1Inhibitors of (alpha-v)(beta-6) integrinHARRISON BRYCE A·Filed 2022·Application pending·0 cites
- 2850US11903936B2Anti-malarial agentsUNIV TEXAS·Filed 2020·Granted Feb 20, 2024·0 cites·24 claims
- 2950US2023365584A1Heterocyclic pericondensed cdc7 kinase inhibitors for the treatment of cancerSCHROEDINGER INC·Filed 2021·Application pending·0 cites
- 3048US2023101747A1Cyclic compounds and methods of using sameSCHROEDINGER INC·Filed 2020·Application pending·0 cites
- 3143US11584763B2Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Feb 21, 2023·0 cites·16 claims
- 3243US2015038438A1Antibacterial compounds and methods for usePTC THERAPEUTICS INC·Filed 2012·Application pending·0 cites
- 3341US9650395B2Antibacterial compounds and methods for useBRANSTROM ARTHUR·Filed 2012·Granted May 16, 2017·0 cites·19 claims
- 3440US11919902B2Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhibitorsHIBERCELL INC·Filed 2018·Granted Mar 5, 2024·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Aleksey I. Gerasyuto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →